Aliskiren Tablet, Film Coated
Product Images NDC 66993-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aliskiren (NDC 66993-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Aliskiren Tablets 2)
The text provides a list of drugs and their recommended doses and adjustments when taken with aliskiren. It specifies that certain drugs such as cyclosporine and atenolol should be avoided, while others like verapamil require no dose adjustment. Overall, the text provides insight into the impact of co-administered drugs on the pharmacokinetics of aliskiren.*
Figure 2 (Aliskiren Tablets 3)
150 mg Label (Aliskiren Tablets 4)
This is a description of a medication with the NDC number 66993-141-30 called Aliskiren Tablets manufactured by Dolpharm Miano SH. The recommended storage temperature is between 69-88°F and it should be kept out of reach of children. The dosage information is not available. It is distributed by Prasco Laboratories in Mason, OH.*
300 mg Label (Aliskiren Tablets 5)
Aliskiren Tablets 6
This is a description of a medication called "Aliskiren Tablets" with a strength of 300 mg, with a National Drug Code (NDC) of 66983-142-30. The manufacturer of the medication is Delpharm Miiano Sr, located in Sagrats, Htal, and it is distributed in Mason, OH. Additional characters and words appear to be errors from and therefore not readable.*
Aliskiren Tablets 7
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.